MATTHEW W. FOEHR - 01 Nov 2022 Form 4 Insider Report for OmniAb, Inc. (OABI)

Role
President & CEO, Director
Signature
/s/ Charles S. Berkman, Attorney-in-Fact
Issuer symbol
OABI
Transactions as of
01 Nov 2022
Transactions value $
$0
Form type
4
Filing time
03 Nov 2022, 21:10:55 UTC
Previous filing
30 Sep 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OABI Common Stock Award +1.31M 1.31M 01 Nov 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OABI Stock Option Award +271K 271K 01 Nov 2022 Common Stock 271K $8.54 Direct F1, F4
transaction OABI Stock Option Award +173K 173K 01 Nov 2022 Common Stock 173K $6.46 Direct F1, F4
transaction OABI Stock Option Award +111K 111K 01 Nov 2022 Common Stock 111K $9.84 Direct F1, F4
transaction OABI Stock Option Award +104K 104K 01 Nov 2022 Common Stock 104K $11.52 Direct F1, F4
transaction OABI Stock Option Award +86.8K 86.8K 01 Nov 2022 Common Stock 86.8K $18.24 Direct F1, F4
transaction OABI Stock Option Award +146K 146K 01 Nov 2022 Common Stock 146K $13.54 Direct F1, F5
transaction OABI Stock Option Award +142K 142K 01 Nov 2022 Common Stock 142K $10.98 Direct F1, F6
transaction OABI Stock Option Award +56.2K 56.2K 01 Nov 2022 Common Stock 56.2K $20.36 Direct F1, F7
transaction OABI Stock Option Award +298K 298K 01 Nov 2022 Common Stock 298K $10.41 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement.
F2 Includes 176,076 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.
F3 Includes 264,760 earn-out shares subject to forfeiture provisions described in the Merger Agreement.
F4 The stock option is fully vested and exercisable.
F5 The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter.
F6 The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter.
F7 The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter.
F8 The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.